Pfizer Inc. (PFE) is an interesting player in the Healthcare space, with a focus on Drug Manufacturers - Major. The Company is engaged in the discovery, development and manufacture of healthcare products. (NYSE:PFE) rating on …
With a market cap of 192182, Pfizer Inc. (NYSE:PFE) has a large market cap size. Pfizer Inc. (NYSE: PFE) has been on the stock market since its IPO date on the 6/1/1972. Pfizer Inc. is in the Drug Manufacturers – Major industry and …
Today Pfizer Inc., (NYSE:PFE) one of the world’s premier biopharmaceutical companies, broke ground on a state-of-the art Research and Development (R&D) and process development facility at 875 W. Chesterfield Parkway, Chesterfield, MO. …
Pfizer Inc. (NYSE:PFE) are rising 0.21% to trade at $34.28. On the relative analysis with scale of 1-5, firm standing at analysts’ recommendation of 2.50. Volatility makes major charm for active investors, so firm has 1.05% volatility for …
The healthcare sector is loaded with great dividend stocks. This should not come as a surprise, since healthcare stocks are stable, and generate reliable profits each year. With their consistent earnings growth, healthcare stocks can pay …
Sell-side analysts reveal their outlook on Pfizer, Inc. (NYSE:PFE) stock. As of 2016-05-24, the stock has ABR of 1.8. This methodology prompts shareholders to invest in stock if it has a rating of 1. The ABR was known considering the price …
FX Empire - the company, employees, subsidiaries and associates, are not liable nor shall they be held liable jointly or severally for any loss or damage as link result of reliance on the information provided on this website. The data …
The institutional investor held 1.06 million shares of the health care company at the end of 2016Q4, valued at $34.51 million, up from 921,340 at the end of the previous reported quarter. Puzo Michael J has 0.22% invested in Pfizer Inc. …
If you're looking for juicy dividends, several big pharmaceutical companies offer some attractive options. The biggest of the bunch in terms of market cap, Johnson & Johnson (NYSE: JNJ), claims a solid dividend yield of 3%. Pfizer (NYSE: …
U.K.-based pharmaceutical company AstraZeneca (AZN) announced on Monday that it has rejected American pharmaceutical firm Pfizer’s (PFE) offer over the weekend to buy the company for 55GBP per share. Pfizer offered $120 …